pharmaobservatory 0.1.5 → 0.1.6
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +114 -7
- data/docs/BiomarkerAssayEvidenceResponse.md +58 -0
- data/docs/{BiomarkerCdxAssertionsResponseBuild.md → BiomarkerAssayEvidenceResponseBuild.md} +2 -2
- data/docs/{BiomarkerCdxAssertionsResponseFreshness.md → BiomarkerAssayEvidenceResponseFreshness.md} +2 -2
- data/docs/{BiomarkerCdxAssertionsResponseScope.md → BiomarkerAssayEvidenceResponseScope.md} +2 -2
- data/docs/BiomarkerAssayEvidenceRow.md +68 -0
- data/docs/BiomarkerAssayWhitespaceResponse.md +58 -0
- data/docs/BiomarkerAssayWhitespaceRow.md +66 -0
- data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
- data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
- data/docs/BiomarkerEvidenceResponse.md +3 -3
- data/docs/BiomarkerLiteratureResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesRow.md +9 -1
- data/docs/BiomarkerRelationsResponse.md +3 -3
- data/docs/BiomarkerSampleCoverageResponse.md +3 -3
- data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
- data/docs/BiomarkerValidationResponse.md +3 -3
- data/docs/BiomarkerVariantMentionsResponse.md +3 -3
- data/docs/BiomarkersApi.md +160 -0
- data/docs/BiomarkersRecord.md +2 -2
- data/docs/BiomarkersResponse.md +3 -3
- data/docs/BiomarkersRow.md +2 -0
- data/docs/CellLinesRecord.md +2 -2
- data/docs/CellLinesResponse.md +3 -3
- data/docs/CompaniesApi.md +246 -0
- data/docs/CompaniesRecord.md +2 -2
- data/docs/CompaniesResponse.md +3 -3
- data/docs/CompaniesRow.md +1 -1
- data/docs/CompanyAssetsResponse.md +3 -3
- data/docs/CompanyFundingEventsResponse.md +3 -3
- data/docs/CompanyFundingEventsRow.md +1 -1
- data/docs/CompanyFundingSummaryResponse.md +3 -3
- data/docs/CompanyMembersResponse.md +3 -3
- data/docs/CompanyProgramsResponse.md +3 -3
- data/docs/CompanyTargetsResponse.md +3 -3
- data/docs/CompanyTargetsRow.md +5 -1
- data/docs/ConditionAdverseEventsResponse.md +3 -3
- data/docs/ConditionBurdenResponse.md +3 -3
- data/docs/ConditionDeliveryResponse.md +3 -3
- data/docs/ConditionDrugsResponse.md +3 -3
- data/docs/ConditionPrevalenceResponse.md +3 -3
- data/docs/ConditionPrevalenceRow.md +1 -1
- data/docs/ConditionPublicationsResponse.md +3 -3
- data/docs/ConditionRecruitmentByPhaseResponse.md +58 -0
- data/docs/ConditionRecruitmentByPhaseRow.md +50 -0
- data/docs/ConditionRecruitmentDurationResponse.md +58 -0
- data/docs/ConditionRecruitmentDurationRow.md +86 -0
- data/docs/ConditionSitesResponse.md +3 -3
- data/docs/ConditionTrialStartForecastResponse.md +58 -0
- data/docs/ConditionTrialStartForecastRow.md +70 -0
- data/docs/ConditionTrialsResponse.md +3 -3
- data/docs/ConditionTrialsRow.md +1 -1
- data/docs/ConditionsApi.md +240 -0
- data/docs/ConditionsRecord.md +2 -2
- data/docs/ConditionsRecordAttributes.md +3 -1
- data/docs/ConditionsResponse.md +3 -3
- data/docs/DrugPatentCliffResponse.md +3 -3
- data/docs/InstitutionalHoldingsResponse.md +3 -3
- data/docs/InstitutionalHoldingsRow.md +7 -1
- data/docs/InvestorFundsResponse.md +58 -0
- data/docs/InvestorFundsRow.md +24 -0
- data/docs/InvestorPortfolioResponse.md +58 -0
- data/docs/InvestorPortfolioRow.md +42 -0
- data/docs/InvestorPrivateFundsResponse.md +58 -0
- data/docs/InvestorPrivateFundsRow.md +44 -0
- data/docs/InvestorsApi.md +633 -0
- data/docs/InvestorsRecord.md +38 -0
- data/docs/InvestorsResponse.md +58 -0
- data/docs/InvestorsRow.md +54 -0
- data/docs/LegalEntitiesApi.md +240 -0
- data/docs/LegalEntitiesRecord.md +2 -2
- data/docs/LegalEntitiesResponse.md +3 -3
- data/docs/LegalEntitiesRow.md +1 -1
- data/docs/ManagersApi.md +233 -0
- data/docs/ManagersRecord.md +38 -0
- data/docs/ManagersResponse.md +58 -0
- data/docs/ManagersRow.md +46 -0
- data/docs/OrgDisclosuresResponse.md +58 -0
- data/docs/OrgDisclosuresRow.md +56 -0
- data/docs/OrgRelationshipsResponse.md +58 -0
- data/docs/OrgRelationshipsRow.md +68 -0
- data/docs/OwnershipPositionsResponse.md +3 -3
- data/docs/OwnershipPositionsRow.md +16 -14
- data/docs/PdufaDatesResponse.md +3 -3
- data/docs/SiteBedsYearlyResponse.md +3 -3
- data/docs/SiteCroTrialsResponse.md +3 -3
- data/docs/SiteHospitalsResponse.md +3 -3
- data/docs/SiteInvestigatorsResponse.md +3 -3
- data/docs/SiteTrialConditionsResponse.md +3 -3
- data/docs/SiteTrialDrugsResponse.md +3 -3
- data/docs/SiteTrialsResponse.md +3 -3
- data/docs/SitesRecord.md +2 -2
- data/docs/SitesResponse.md +3 -3
- data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
- data/docs/SponsorRecruitmentDurationResponse.md +3 -3
- data/docs/SponsorTrialStartForecastResponse.md +3 -3
- data/docs/SponsorTrialsResponse.md +3 -3
- data/docs/SponsorTrialsRow.md +1 -1
- data/docs/SupplierCapabilityEsgResponse.md +58 -0
- data/docs/SupplierCapabilityEsgRow.md +64 -0
- data/docs/SupplierServicesResponse.md +58 -0
- data/docs/SupplierServicesRow.md +30 -0
- data/docs/SupplierSitesResponse.md +58 -0
- data/docs/SupplierSitesRow.md +42 -0
- data/docs/SuppliersApi.md +313 -0
- data/docs/SuppliersRecord.md +38 -0
- data/docs/SuppliersResponse.md +58 -0
- data/docs/SuppliersRow.md +76 -0
- data/docs/TargetAssociationsResponse.md +58 -0
- data/docs/TargetAssociationsRow.md +26 -0
- data/docs/TargetCrowdingResponse.md +58 -0
- data/docs/TargetCrowdingRow.md +30 -0
- data/docs/TargetDrugsResponse.md +58 -0
- data/docs/TargetDrugsRow.md +38 -0
- data/docs/TargetEvidenceResponse.md +58 -0
- data/docs/TargetEvidenceRow.md +52 -0
- data/docs/TargetPatentMentionsResponse.md +58 -0
- data/docs/TargetPatentMentionsRow.md +34 -0
- data/docs/TargetProgramsResponse.md +58 -0
- data/docs/TargetProgramsRow.md +58 -0
- data/docs/TargetPublicationsResponse.md +58 -0
- data/docs/TargetPublicationsRow.md +32 -0
- data/docs/TargetRegulatoryPrecedentResponse.md +58 -0
- data/docs/TargetRegulatoryPrecedentRow.md +38 -0
- data/docs/TargetTrialsResponse.md +58 -0
- data/docs/TargetTrialsRow.md +46 -0
- data/docs/TargetsApi.md +1033 -0
- data/docs/TargetsRecord.md +38 -0
- data/docs/TargetsResponse.md +58 -0
- data/docs/TargetsRow.md +68 -0
- data/docs/TrialAdverseEventsResponse.md +3 -3
- data/docs/TrialChangesResponse.md +3 -3
- data/docs/TrialDeliveryResponse.md +3 -3
- data/docs/TrialDemographicsResponse.md +3 -3
- data/docs/TrialDrugClassesResponse.md +58 -0
- data/docs/TrialDrugClassesRow.md +28 -0
- data/docs/TrialDrugsResponse.md +3 -3
- data/docs/TrialEnrollmentHistoryResponse.md +3 -3
- data/docs/TrialEnrollmentRateResponse.md +3 -3
- data/docs/TrialExtractedEndpointsResponse.md +3 -3
- data/docs/TrialKolsResponse.md +58 -0
- data/docs/TrialKolsRow.md +32 -0
- data/docs/TrialOutcomeMeasuresResponse.md +3 -3
- data/docs/TrialResearchPaymentsResponse.md +58 -0
- data/docs/TrialResearchPaymentsRow.md +44 -0
- data/docs/TrialSiteHistoryResponse.md +58 -0
- data/docs/TrialSiteHistoryRow.md +50 -0
- data/docs/TrialSitesResponse.md +3 -3
- data/docs/TrialsApi.md +320 -0
- data/docs/TrialsRecord.md +2 -2
- data/docs/TrialsResponse.md +3 -3
- data/lib/pharmaobservatory/api/biomarkers_api.rb +168 -0
- data/lib/pharmaobservatory/api/companies_api.rb +273 -0
- data/lib/pharmaobservatory/api/conditions_api.rb +252 -0
- data/lib/pharmaobservatory/api/investors_api.rb +665 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +252 -0
- data/lib/pharmaobservatory/api/managers_api.rb +245 -0
- data/lib/pharmaobservatory/api/suppliers_api.rb +329 -0
- data/lib/pharmaobservatory/api/targets_api.rb +1085 -0
- data/lib/pharmaobservatory/api/trials_api.rb +336 -0
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_build.rb → biomarker_assay_evidence_response_build.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_freshness.rb → biomarker_assay_evidence_response_freshness.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_scope.rb → biomarker_assay_evidence_response_scope.rb} +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb +506 -0
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb +499 -0
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb +49 -5
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
- data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_row.rb +12 -1
- data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_record.rb +2 -2
- data/lib/pharmaobservatory/models/companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_row.rb +1 -1
- data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_events_row.rb +1 -1
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_targets_row.rb +27 -5
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_prevalence_row.rb +1 -1
- data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_row.rb +399 -0
- data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_recruitment_duration_row.rb +597 -0
- data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_row.rb +509 -0
- data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trials_row.rb +1 -1
- data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
- data/lib/pharmaobservatory/models/conditions_record_attributes.rb +13 -4
- data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_row.rb +35 -2
- data/lib/pharmaobservatory/models/investor_funds_response.rb +478 -0
- data/lib/pharmaobservatory/models/investor_funds_row.rb +256 -0
- data/lib/pharmaobservatory/models/investor_portfolio_response.rb +478 -0
- data/lib/pharmaobservatory/models/investor_portfolio_row.rb +357 -0
- data/lib/pharmaobservatory/models/investor_private_funds_response.rb +478 -0
- data/lib/pharmaobservatory/models/investor_private_funds_row.rb +366 -0
- data/lib/pharmaobservatory/models/investors_record.rb +385 -0
- data/lib/pharmaobservatory/models/investors_response.rb +478 -0
- data/lib/pharmaobservatory/models/investors_row.rb +421 -0
- data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
- data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
- data/lib/pharmaobservatory/models/legal_entities_row.rb +1 -1
- data/lib/pharmaobservatory/models/managers_record.rb +385 -0
- data/lib/pharmaobservatory/models/managers_response.rb +478 -0
- data/lib/pharmaobservatory/models/managers_row.rb +377 -0
- data/lib/pharmaobservatory/models/org_disclosures_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosures_row.rb +432 -0
- data/lib/pharmaobservatory/models/org_relationships_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_relationships_row.rb +498 -0
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_positions_row.rb +26 -15
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sites_record.rb +2 -2
- data/lib/pharmaobservatory/models/sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_row.rb +1 -1
- data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +478 -0
- data/lib/pharmaobservatory/models/supplier_capability_esg_row.rb +480 -0
- data/lib/pharmaobservatory/models/supplier_services_response.rb +478 -0
- data/lib/pharmaobservatory/models/supplier_services_row.rb +289 -0
- data/lib/pharmaobservatory/models/supplier_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/supplier_sites_row.rb +357 -0
- data/lib/pharmaobservatory/models/suppliers_record.rb +385 -0
- data/lib/pharmaobservatory/models/suppliers_response.rb +478 -0
- data/lib/pharmaobservatory/models/suppliers_row.rb +544 -0
- data/lib/pharmaobservatory/models/target_associations_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_associations_row.rb +267 -0
- data/lib/pharmaobservatory/models/target_crowding_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_crowding_row.rb +289 -0
- data/lib/pharmaobservatory/models/target_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_drugs_row.rb +335 -0
- data/lib/pharmaobservatory/models/target_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_evidence_row.rb +410 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_row.rb +311 -0
- data/lib/pharmaobservatory/models/target_programs_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_programs_row.rb +447 -0
- data/lib/pharmaobservatory/models/target_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_publications_row.rb +300 -0
- data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_regulatory_precedent_row.rb +333 -0
- data/lib/pharmaobservatory/models/target_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_trials_row.rb +377 -0
- data/lib/pharmaobservatory/models/targets_record.rb +385 -0
- data/lib/pharmaobservatory/models/targets_response.rb +478 -0
- data/lib/pharmaobservatory/models/targets_row.rb +498 -0
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_drug_classes_row.rb +278 -0
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_kols_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_kols_row.rb +302 -0
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_research_payments_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_research_payments_row.rb +366 -0
- data/lib/pharmaobservatory/models/trial_site_history_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_site_history_row.rb +401 -0
- data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_record.rb +2 -2
- data/lib/pharmaobservatory/models/trials_response.rb +3 -3
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +71 -3
- metadata +144 -8
checksums.yaml
CHANGED
|
@@ -1,7 +1,7 @@
|
|
|
1
1
|
---
|
|
2
2
|
SHA256:
|
|
3
|
-
metadata.gz:
|
|
4
|
-
data.tar.gz:
|
|
3
|
+
metadata.gz: b82da297e53a1f5dbae57ddecb86e657a5e50c8326f395b6af2fdf2a410e67ab
|
|
4
|
+
data.tar.gz: d18dbfa131b5176148287daf592e588c5b90acda9a1493755711cf5057ee2715
|
|
5
5
|
SHA512:
|
|
6
|
-
metadata.gz:
|
|
7
|
-
data.tar.gz:
|
|
6
|
+
metadata.gz: 503edb3a8c8067335e597af7a692cee88188e97860bc1893a19fbab90636a160ef5a3910ee432df4142f09befaff17187b01b99b387b0a4a1895d7267c528aa4
|
|
7
|
+
data.tar.gz: d2e63ebabf4728719fbc292d97d548bdd1aad6b55cffeb6677273620328ce519df4af924e9bf4ff982bdc24c83451cd7eb07abdc12abb3599813c22d23881e10
|
data/README.md
CHANGED
|
@@ -39,7 +39,7 @@ Read-only REST API over the Pharma Observatory biomedical data platform. Referen
|
|
|
39
39
|
This SDK is automatically generated by the [OpenAPI Generator](https://openapi-generator.tech) project:
|
|
40
40
|
|
|
41
41
|
- API version: 1.0.0
|
|
42
|
-
- Package version: 0.1.
|
|
42
|
+
- Package version: 0.1.6
|
|
43
43
|
- Generator version: 7.13.0
|
|
44
44
|
- Build package: org.openapitools.codegen.languages.RubyClientCodegen
|
|
45
45
|
|
|
@@ -56,16 +56,16 @@ gem build pharmaobservatory.gemspec
|
|
|
56
56
|
Then either install the gem locally:
|
|
57
57
|
|
|
58
58
|
```shell
|
|
59
|
-
gem install ./pharmaobservatory-0.1.
|
|
59
|
+
gem install ./pharmaobservatory-0.1.6.gem
|
|
60
60
|
```
|
|
61
61
|
|
|
62
|
-
(for development, run `gem install --dev ./pharmaobservatory-0.1.
|
|
62
|
+
(for development, run `gem install --dev ./pharmaobservatory-0.1.6.gem` to install the development dependencies)
|
|
63
63
|
|
|
64
64
|
or publish the gem to a gem hosting service, e.g. [RubyGems](https://rubygems.org/).
|
|
65
65
|
|
|
66
66
|
Finally add this to the Gemfile:
|
|
67
67
|
|
|
68
|
-
gem 'pharmaobservatory', '~> 0.1.
|
|
68
|
+
gem 'pharmaobservatory', '~> 0.1.6'
|
|
69
69
|
|
|
70
70
|
### Install from Git
|
|
71
71
|
|
|
@@ -118,6 +118,8 @@ All URIs are relative to *https://pharmaobservatory.com*
|
|
|
118
118
|
Class | Method | HTTP request | Description
|
|
119
119
|
------------ | ------------- | ------------- | -------------
|
|
120
120
|
*PharmaObservatory::ApiV1BaseApi* | [**api_v1_whoami_get**](docs/ApiV1BaseApi.md#api_v1_whoami_get) | **GET** /api/v1/whoami | whoami
|
|
121
|
+
*PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_assay_evidence**](docs/BiomarkersApi.md#biomarkers_biomarker_assay_evidence) | **GET** /api/v1/biomarkers/{id}/biomarker_assay_evidence | Biomarker assay evidence from the literature
|
|
122
|
+
*PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_assay_whitespace**](docs/BiomarkersApi.md#biomarkers_biomarker_assay_whitespace) | **GET** /api/v1/biomarkers/{id}/biomarker_assay_whitespace | Biomarker assay whitespace (evidence against supplier supply)
|
|
121
123
|
*PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_bqp_assertions**](docs/BiomarkersApi.md#biomarkers_biomarker_bqp_assertions) | **GET** /api/v1/biomarkers/{id}/biomarker_bqp_assertions | FDA biomarker qualification projects
|
|
122
124
|
*PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_cdx_assertions**](docs/BiomarkersApi.md#biomarkers_biomarker_cdx_assertions) | **GET** /api/v1/biomarkers/{id}/biomarker_cdx_assertions | FDA companion diagnostic assertions
|
|
123
125
|
*PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_evidence**](docs/BiomarkersApi.md#biomarkers_biomarker_evidence) | **GET** /api/v1/biomarkers/{id}/biomarker_evidence | Biomarker evidence
|
|
@@ -147,12 +149,15 @@ Class | Method | HTTP request | Description
|
|
|
147
149
|
*PharmaObservatory::CompaniesApi* | [**companies_institutional_holdings**](docs/CompaniesApi.md#companies_institutional_holdings) | **GET** /api/v1/companies/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
|
|
148
150
|
*PharmaObservatory::CompaniesApi* | [**companies_legal_entities**](docs/CompaniesApi.md#companies_legal_entities) | **GET** /api/v1/companies/{id}/legal_entities | Legal entities
|
|
149
151
|
*PharmaObservatory::CompaniesApi* | [**companies_list**](docs/CompaniesApi.md#companies_list) | **GET** /api/v1/companies | List companies
|
|
152
|
+
*PharmaObservatory::CompaniesApi* | [**companies_org_disclosures**](docs/CompaniesApi.md#companies_org_disclosures) | **GET** /api/v1/companies/{id}/org_disclosures | Organization disclosures (climate and diversity)
|
|
153
|
+
*PharmaObservatory::CompaniesApi* | [**companies_org_relationships**](docs/CompaniesApi.md#companies_org_relationships) | **GET** /api/v1/companies/{id}/org_relationships | Organization relationships
|
|
150
154
|
*PharmaObservatory::CompaniesApi* | [**companies_ownership_positions**](docs/CompaniesApi.md#companies_ownership_positions) | **GET** /api/v1/companies/{id}/ownership_positions | Ownership and control positions
|
|
151
155
|
*PharmaObservatory::CompaniesApi* | [**companies_pdufa_dates**](docs/CompaniesApi.md#companies_pdufa_dates) | **GET** /api/v1/companies/{id}/pdufa_dates | FDA decision dates (PDUFA) and catalysts
|
|
152
156
|
*PharmaObservatory::CompaniesApi* | [**companies_sponsor_recruitment_by_phase**](docs/CompaniesApi.md#companies_sponsor_recruitment_by_phase) | **GET** /api/v1/companies/{id}/sponsor_recruitment_by_phase | Trial recruitment duration by sponsor and phase
|
|
153
157
|
*PharmaObservatory::CompaniesApi* | [**companies_sponsor_recruitment_duration**](docs/CompaniesApi.md#companies_sponsor_recruitment_duration) | **GET** /api/v1/companies/{id}/sponsor_recruitment_duration | Trial recruitment duration by sponsor
|
|
154
158
|
*PharmaObservatory::CompaniesApi* | [**companies_sponsor_trial_start_forecast**](docs/CompaniesApi.md#companies_sponsor_trial_start_forecast) | **GET** /api/v1/companies/{id}/sponsor_trial_start_forecast | Trial-start forecast by sponsor
|
|
155
159
|
*PharmaObservatory::CompaniesApi* | [**companies_sponsor_trials**](docs/CompaniesApi.md#companies_sponsor_trials) | **GET** /api/v1/companies/{id}/sponsor_trials | Sponsor trials
|
|
160
|
+
*PharmaObservatory::CompaniesApi* | [**companies_supplier_capability_esg**](docs/CompaniesApi.md#companies_supplier_capability_esg) | **GET** /api/v1/companies/{id}/supplier_capability_esg | Supplier capability and ESG disclosure
|
|
156
161
|
*PharmaObservatory::ConditionsApi* | [**conditions_company_programs**](docs/ConditionsApi.md#conditions_company_programs) | **GET** /api/v1/conditions/{id}/company_programs | Company programs
|
|
157
162
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_adverse_events**](docs/ConditionsApi.md#conditions_condition_adverse_events) | **GET** /api/v1/conditions/{id}/condition_adverse_events | Condition adverse events
|
|
158
163
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_burden**](docs/ConditionsApi.md#conditions_condition_burden) | **GET** /api/v1/conditions/{id}/condition_burden | Condition burden
|
|
@@ -160,25 +165,42 @@ Class | Method | HTTP request | Description
|
|
|
160
165
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_drugs**](docs/ConditionsApi.md#conditions_condition_drugs) | **GET** /api/v1/conditions/{id}/condition_drugs | Condition drugs
|
|
161
166
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_prevalence**](docs/ConditionsApi.md#conditions_condition_prevalence) | **GET** /api/v1/conditions/{id}/condition_prevalence | Condition prevalence
|
|
162
167
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_publications**](docs/ConditionsApi.md#conditions_condition_publications) | **GET** /api/v1/conditions/{id}/condition_publications | Condition publications
|
|
168
|
+
*PharmaObservatory::ConditionsApi* | [**conditions_condition_recruitment_by_phase**](docs/ConditionsApi.md#conditions_condition_recruitment_by_phase) | **GET** /api/v1/conditions/{id}/condition_recruitment_by_phase | Trial recruitment duration by condition and phase
|
|
169
|
+
*PharmaObservatory::ConditionsApi* | [**conditions_condition_recruitment_duration**](docs/ConditionsApi.md#conditions_condition_recruitment_duration) | **GET** /api/v1/conditions/{id}/condition_recruitment_duration | Trial recruitment duration by condition
|
|
163
170
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_sites**](docs/ConditionsApi.md#conditions_condition_sites) | **GET** /api/v1/conditions/{id}/condition_sites | Condition sites
|
|
171
|
+
*PharmaObservatory::ConditionsApi* | [**conditions_condition_trial_start_forecast**](docs/ConditionsApi.md#conditions_condition_trial_start_forecast) | **GET** /api/v1/conditions/{id}/condition_trial_start_forecast | Trial-start forecast by condition
|
|
164
172
|
*PharmaObservatory::ConditionsApi* | [**conditions_condition_trials**](docs/ConditionsApi.md#conditions_condition_trials) | **GET** /api/v1/conditions/{id}/condition_trials | Condition trials
|
|
165
173
|
*PharmaObservatory::ConditionsApi* | [**conditions_get**](docs/ConditionsApi.md#conditions_get) | **GET** /api/v1/conditions/{id} | One condition
|
|
166
174
|
*PharmaObservatory::ConditionsApi* | [**conditions_list**](docs/ConditionsApi.md#conditions_list) | **GET** /api/v1/conditions | List conditions
|
|
167
175
|
*PharmaObservatory::ConditionsApi* | [**conditions_pdufa_dates**](docs/ConditionsApi.md#conditions_pdufa_dates) | **GET** /api/v1/conditions/{id}/pdufa_dates | FDA decision dates (PDUFA) and catalysts
|
|
168
176
|
*PharmaObservatory::DatasetsApi* | [**datasets_get**](docs/DatasetsApi.md#datasets_get) | **GET** /api/v1/datasets/{name} | Describe a dataset
|
|
169
177
|
*PharmaObservatory::DatasetsApi* | [**datasets_list**](docs/DatasetsApi.md#datasets_list) | **GET** /api/v1/datasets | List the datasets
|
|
178
|
+
*PharmaObservatory::InvestorsApi* | [**investors_get**](docs/InvestorsApi.md#investors_get) | **GET** /api/v1/investors/{id} | One investor
|
|
179
|
+
*PharmaObservatory::InvestorsApi* | [**investors_institutional_holdings**](docs/InvestorsApi.md#investors_institutional_holdings) | **GET** /api/v1/investors/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
|
|
180
|
+
*PharmaObservatory::InvestorsApi* | [**investors_investor_funds**](docs/InvestorsApi.md#investors_investor_funds) | **GET** /api/v1/investors/{id}/investor_funds | Investor private funds by type
|
|
181
|
+
*PharmaObservatory::InvestorsApi* | [**investors_investor_portfolio**](docs/InvestorsApi.md#investors_investor_portfolio) | **GET** /api/v1/investors/{id}/investor_portfolio | Investor portfolio (offering filings)
|
|
182
|
+
*PharmaObservatory::InvestorsApi* | [**investors_investor_private_funds**](docs/InvestorsApi.md#investors_investor_private_funds) | **GET** /api/v1/investors/{id}/investor_private_funds | Investor private funds
|
|
183
|
+
*PharmaObservatory::InvestorsApi* | [**investors_list**](docs/InvestorsApi.md#investors_list) | **GET** /api/v1/investors | List investors
|
|
184
|
+
*PharmaObservatory::InvestorsApi* | [**investors_managers**](docs/InvestorsApi.md#investors_managers) | **GET** /api/v1/investors/{id}/managers | Institutional managers (SEC Form 13F)
|
|
185
|
+
*PharmaObservatory::InvestorsApi* | [**investors_ownership_positions**](docs/InvestorsApi.md#investors_ownership_positions) | **GET** /api/v1/investors/{id}/ownership_positions | Ownership and control positions
|
|
170
186
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_company_assets**](docs/LegalEntitiesApi.md#legal_entities_company_assets) | **GET** /api/v1/legal_entities/{id}/company_assets | Company assets (approved and marketed drugs)
|
|
171
187
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_company_programs**](docs/LegalEntitiesApi.md#legal_entities_company_programs) | **GET** /api/v1/legal_entities/{id}/company_programs | Company programs
|
|
172
188
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_drug_patent_cliff**](docs/LegalEntitiesApi.md#legal_entities_drug_patent_cliff) | **GET** /api/v1/legal_entities/{id}/drug_patent_cliff | Patent-cliff exposure
|
|
173
189
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_get**](docs/LegalEntitiesApi.md#legal_entities_get) | **GET** /api/v1/legal_entities/{id} | One legal entity
|
|
174
190
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_institutional_holdings**](docs/LegalEntitiesApi.md#legal_entities_institutional_holdings) | **GET** /api/v1/legal_entities/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
|
|
175
191
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_list**](docs/LegalEntitiesApi.md#legal_entities_list) | **GET** /api/v1/legal_entities | List legal entities
|
|
192
|
+
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_org_disclosures**](docs/LegalEntitiesApi.md#legal_entities_org_disclosures) | **GET** /api/v1/legal_entities/{id}/org_disclosures | Organization disclosures (climate and diversity)
|
|
193
|
+
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_org_relationships**](docs/LegalEntitiesApi.md#legal_entities_org_relationships) | **GET** /api/v1/legal_entities/{id}/org_relationships | Organization relationships
|
|
176
194
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_ownership_positions**](docs/LegalEntitiesApi.md#legal_entities_ownership_positions) | **GET** /api/v1/legal_entities/{id}/ownership_positions | Ownership and control positions
|
|
177
195
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_pdufa_dates**](docs/LegalEntitiesApi.md#legal_entities_pdufa_dates) | **GET** /api/v1/legal_entities/{id}/pdufa_dates | FDA decision dates (PDUFA) and catalysts
|
|
178
196
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_recruitment_by_phase**](docs/LegalEntitiesApi.md#legal_entities_sponsor_recruitment_by_phase) | **GET** /api/v1/legal_entities/{id}/sponsor_recruitment_by_phase | Trial recruitment duration by sponsor and phase
|
|
179
197
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_recruitment_duration**](docs/LegalEntitiesApi.md#legal_entities_sponsor_recruitment_duration) | **GET** /api/v1/legal_entities/{id}/sponsor_recruitment_duration | Trial recruitment duration by sponsor
|
|
180
198
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_trial_start_forecast**](docs/LegalEntitiesApi.md#legal_entities_sponsor_trial_start_forecast) | **GET** /api/v1/legal_entities/{id}/sponsor_trial_start_forecast | Trial-start forecast by sponsor
|
|
181
199
|
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_trials**](docs/LegalEntitiesApi.md#legal_entities_sponsor_trials) | **GET** /api/v1/legal_entities/{id}/sponsor_trials | Sponsor trials
|
|
200
|
+
*PharmaObservatory::LegalEntitiesApi* | [**legal_entities_supplier_capability_esg**](docs/LegalEntitiesApi.md#legal_entities_supplier_capability_esg) | **GET** /api/v1/legal_entities/{id}/supplier_capability_esg | Supplier capability and ESG disclosure
|
|
201
|
+
*PharmaObservatory::ManagersApi* | [**managers_get**](docs/ManagersApi.md#managers_get) | **GET** /api/v1/managers/{id} | One form 13f manager
|
|
202
|
+
*PharmaObservatory::ManagersApi* | [**managers_institutional_holdings**](docs/ManagersApi.md#managers_institutional_holdings) | **GET** /api/v1/managers/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
|
|
203
|
+
*PharmaObservatory::ManagersApi* | [**managers_list**](docs/ManagersApi.md#managers_list) | **GET** /api/v1/managers | List form 13f managers
|
|
182
204
|
*PharmaObservatory::QueryApi* | [**query_result**](docs/QueryApi.md#query_result) | **GET** /api/v1/results/{result_id} | Page a stored result
|
|
183
205
|
*PharmaObservatory::QueryApi* | [**query_run**](docs/QueryApi.md#query_run) | **POST** /api/v1/query | Run a SQL query
|
|
184
206
|
*PharmaObservatory::SitesApi* | [**sites_get**](docs/SitesApi.md#sites_get) | **GET** /api/v1/sites/{id} | One site
|
|
@@ -190,6 +212,23 @@ Class | Method | HTTP request | Description
|
|
|
190
212
|
*PharmaObservatory::SitesApi* | [**sites_site_trial_conditions**](docs/SitesApi.md#sites_site_trial_conditions) | **GET** /api/v1/sites/{id}/site_trial_conditions | Site trial conditions
|
|
191
213
|
*PharmaObservatory::SitesApi* | [**sites_site_trial_drugs**](docs/SitesApi.md#sites_site_trial_drugs) | **GET** /api/v1/sites/{id}/site_trial_drugs | Site trial drugs
|
|
192
214
|
*PharmaObservatory::SitesApi* | [**sites_site_trials**](docs/SitesApi.md#sites_site_trials) | **GET** /api/v1/sites/{id}/site_trials | Site trials
|
|
215
|
+
*PharmaObservatory::SuppliersApi* | [**suppliers_get**](docs/SuppliersApi.md#suppliers_get) | **GET** /api/v1/suppliers/{id} | One supplier
|
|
216
|
+
*PharmaObservatory::SuppliersApi* | [**suppliers_list**](docs/SuppliersApi.md#suppliers_list) | **GET** /api/v1/suppliers | List suppliers
|
|
217
|
+
*PharmaObservatory::SuppliersApi* | [**suppliers_supplier_services**](docs/SuppliersApi.md#suppliers_supplier_services) | **GET** /api/v1/suppliers/{id}/supplier_services | Supplier services
|
|
218
|
+
*PharmaObservatory::SuppliersApi* | [**suppliers_supplier_sites**](docs/SuppliersApi.md#suppliers_supplier_sites) | **GET** /api/v1/suppliers/{id}/supplier_sites | Supplier sites
|
|
219
|
+
*PharmaObservatory::TargetsApi* | [**targets_biomarker_evidence**](docs/TargetsApi.md#targets_biomarker_evidence) | **GET** /api/v1/targets/{id}/biomarker_evidence | Biomarker evidence
|
|
220
|
+
*PharmaObservatory::TargetsApi* | [**targets_company_targets**](docs/TargetsApi.md#targets_company_targets) | **GET** /api/v1/targets/{id}/company_targets | Targets a company pursues
|
|
221
|
+
*PharmaObservatory::TargetsApi* | [**targets_get**](docs/TargetsApi.md#targets_get) | **GET** /api/v1/targets/{id} | One target
|
|
222
|
+
*PharmaObservatory::TargetsApi* | [**targets_list**](docs/TargetsApi.md#targets_list) | **GET** /api/v1/targets | List targets
|
|
223
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_associations**](docs/TargetsApi.md#targets_target_associations) | **GET** /api/v1/targets/{id}/target_associations | Target-disease associations by datasource
|
|
224
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_crowding**](docs/TargetsApi.md#targets_target_crowding) | **GET** /api/v1/targets/{id}/target_crowding | Target crowding by phase
|
|
225
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_drugs**](docs/TargetsApi.md#targets_target_drugs) | **GET** /api/v1/targets/{id}/target_drugs | Drugs acting on a target
|
|
226
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_evidence**](docs/TargetsApi.md#targets_target_evidence) | **GET** /api/v1/targets/{id}/target_evidence | Target evidence
|
|
227
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_patent_mentions**](docs/TargetsApi.md#targets_target_patent_mentions) | **GET** /api/v1/targets/{id}/target_patent_mentions | Target patent mentions
|
|
228
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_programs**](docs/TargetsApi.md#targets_target_programs) | **GET** /api/v1/targets/{id}/target_programs | Target development programs
|
|
229
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_publications**](docs/TargetsApi.md#targets_target_publications) | **GET** /api/v1/targets/{id}/target_publications | Target publications
|
|
230
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_regulatory_precedent**](docs/TargetsApi.md#targets_target_regulatory_precedent) | **GET** /api/v1/targets/{id}/target_regulatory_precedent | Target regulatory precedent
|
|
231
|
+
*PharmaObservatory::TargetsApi* | [**targets_target_trials**](docs/TargetsApi.md#targets_target_trials) | **GET** /api/v1/targets/{id}/target_trials | Trials targeting a target
|
|
193
232
|
*PharmaObservatory::TrialsApi* | [**trials_get**](docs/TrialsApi.md#trials_get) | **GET** /api/v1/trials/{id} | One trial
|
|
194
233
|
*PharmaObservatory::TrialsApi* | [**trials_list**](docs/TrialsApi.md#trials_list) | **GET** /api/v1/trials | List trials
|
|
195
234
|
*PharmaObservatory::TrialsApi* | [**trials_sponsor_trials**](docs/TrialsApi.md#trials_sponsor_trials) | **GET** /api/v1/trials/{id}/sponsor_trials | Sponsor trials
|
|
@@ -197,11 +236,15 @@ Class | Method | HTTP request | Description
|
|
|
197
236
|
*PharmaObservatory::TrialsApi* | [**trials_trial_changes**](docs/TrialsApi.md#trials_trial_changes) | **GET** /api/v1/trials/{id}/trial_changes | Trial changes
|
|
198
237
|
*PharmaObservatory::TrialsApi* | [**trials_trial_delivery**](docs/TrialsApi.md#trials_trial_delivery) | **GET** /api/v1/trials/{id}/trial_delivery | Trial delivery
|
|
199
238
|
*PharmaObservatory::TrialsApi* | [**trials_trial_demographics**](docs/TrialsApi.md#trials_trial_demographics) | **GET** /api/v1/trials/{id}/trial_demographics | Trial demographics
|
|
239
|
+
*PharmaObservatory::TrialsApi* | [**trials_trial_drug_classes**](docs/TrialsApi.md#trials_trial_drug_classes) | **GET** /api/v1/trials/{id}/trial_drug_classes | Trial drug classes
|
|
200
240
|
*PharmaObservatory::TrialsApi* | [**trials_trial_drugs**](docs/TrialsApi.md#trials_trial_drugs) | **GET** /api/v1/trials/{id}/trial_drugs | Trial drugs
|
|
201
241
|
*PharmaObservatory::TrialsApi* | [**trials_trial_enrollment_history**](docs/TrialsApi.md#trials_trial_enrollment_history) | **GET** /api/v1/trials/{id}/trial_enrollment_history | Trial enrollment history
|
|
202
242
|
*PharmaObservatory::TrialsApi* | [**trials_trial_enrollment_rate**](docs/TrialsApi.md#trials_trial_enrollment_rate) | **GET** /api/v1/trials/{id}/trial_enrollment_rate | Trial enrollment rate
|
|
203
243
|
*PharmaObservatory::TrialsApi* | [**trials_trial_extracted_endpoints**](docs/TrialsApi.md#trials_trial_extracted_endpoints) | **GET** /api/v1/trials/{id}/trial_extracted_endpoints | Trial extracted endpoints
|
|
244
|
+
*PharmaObservatory::TrialsApi* | [**trials_trial_kols**](docs/TrialsApi.md#trials_trial_kols) | **GET** /api/v1/trials/{id}/trial_kols | Trial investigators
|
|
204
245
|
*PharmaObservatory::TrialsApi* | [**trials_trial_outcome_measures**](docs/TrialsApi.md#trials_trial_outcome_measures) | **GET** /api/v1/trials/{id}/trial_outcome_measures | Trial outcome measures
|
|
246
|
+
*PharmaObservatory::TrialsApi* | [**trials_trial_research_payments**](docs/TrialsApi.md#trials_trial_research_payments) | **GET** /api/v1/trials/{id}/trial_research_payments | Trial research payments
|
|
247
|
+
*PharmaObservatory::TrialsApi* | [**trials_trial_site_history**](docs/TrialsApi.md#trials_trial_site_history) | **GET** /api/v1/trials/{id}/trial_site_history | Trial site history
|
|
205
248
|
*PharmaObservatory::TrialsApi* | [**trials_trial_sites**](docs/TrialsApi.md#trials_trial_sites) | **GET** /api/v1/trials/{id}/trial_sites | Trial sites
|
|
206
249
|
|
|
207
250
|
|
|
@@ -213,12 +256,16 @@ Class | Method | HTTP request | Description
|
|
|
213
256
|
- [PharmaObservatory::ApiV1WhoamiGet200ResponseQuotaBuckets](docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md)
|
|
214
257
|
- [PharmaObservatory::ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute](docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md)
|
|
215
258
|
- [PharmaObservatory::AuthError](docs/AuthError.md)
|
|
259
|
+
- [PharmaObservatory::BiomarkerAssayEvidenceResponse](docs/BiomarkerAssayEvidenceResponse.md)
|
|
260
|
+
- [PharmaObservatory::BiomarkerAssayEvidenceResponseBuild](docs/BiomarkerAssayEvidenceResponseBuild.md)
|
|
261
|
+
- [PharmaObservatory::BiomarkerAssayEvidenceResponseFreshness](docs/BiomarkerAssayEvidenceResponseFreshness.md)
|
|
262
|
+
- [PharmaObservatory::BiomarkerAssayEvidenceResponseScope](docs/BiomarkerAssayEvidenceResponseScope.md)
|
|
263
|
+
- [PharmaObservatory::BiomarkerAssayEvidenceRow](docs/BiomarkerAssayEvidenceRow.md)
|
|
264
|
+
- [PharmaObservatory::BiomarkerAssayWhitespaceResponse](docs/BiomarkerAssayWhitespaceResponse.md)
|
|
265
|
+
- [PharmaObservatory::BiomarkerAssayWhitespaceRow](docs/BiomarkerAssayWhitespaceRow.md)
|
|
216
266
|
- [PharmaObservatory::BiomarkerBqpAssertionsResponse](docs/BiomarkerBqpAssertionsResponse.md)
|
|
217
267
|
- [PharmaObservatory::BiomarkerBqpAssertionsRow](docs/BiomarkerBqpAssertionsRow.md)
|
|
218
268
|
- [PharmaObservatory::BiomarkerCdxAssertionsResponse](docs/BiomarkerCdxAssertionsResponse.md)
|
|
219
|
-
- [PharmaObservatory::BiomarkerCdxAssertionsResponseBuild](docs/BiomarkerCdxAssertionsResponseBuild.md)
|
|
220
|
-
- [PharmaObservatory::BiomarkerCdxAssertionsResponseFreshness](docs/BiomarkerCdxAssertionsResponseFreshness.md)
|
|
221
|
-
- [PharmaObservatory::BiomarkerCdxAssertionsResponseScope](docs/BiomarkerCdxAssertionsResponseScope.md)
|
|
222
269
|
- [PharmaObservatory::BiomarkerCdxAssertionsRow](docs/BiomarkerCdxAssertionsRow.md)
|
|
223
270
|
- [PharmaObservatory::BiomarkerEvidenceResponse](docs/BiomarkerEvidenceResponse.md)
|
|
224
271
|
- [PharmaObservatory::BiomarkerEvidenceRow](docs/BiomarkerEvidenceRow.md)
|
|
@@ -270,8 +317,14 @@ Class | Method | HTTP request | Description
|
|
|
270
317
|
- [PharmaObservatory::ConditionPrevalenceRow](docs/ConditionPrevalenceRow.md)
|
|
271
318
|
- [PharmaObservatory::ConditionPublicationsResponse](docs/ConditionPublicationsResponse.md)
|
|
272
319
|
- [PharmaObservatory::ConditionPublicationsRow](docs/ConditionPublicationsRow.md)
|
|
320
|
+
- [PharmaObservatory::ConditionRecruitmentByPhaseResponse](docs/ConditionRecruitmentByPhaseResponse.md)
|
|
321
|
+
- [PharmaObservatory::ConditionRecruitmentByPhaseRow](docs/ConditionRecruitmentByPhaseRow.md)
|
|
322
|
+
- [PharmaObservatory::ConditionRecruitmentDurationResponse](docs/ConditionRecruitmentDurationResponse.md)
|
|
323
|
+
- [PharmaObservatory::ConditionRecruitmentDurationRow](docs/ConditionRecruitmentDurationRow.md)
|
|
273
324
|
- [PharmaObservatory::ConditionSitesResponse](docs/ConditionSitesResponse.md)
|
|
274
325
|
- [PharmaObservatory::ConditionSitesRow](docs/ConditionSitesRow.md)
|
|
326
|
+
- [PharmaObservatory::ConditionTrialStartForecastResponse](docs/ConditionTrialStartForecastResponse.md)
|
|
327
|
+
- [PharmaObservatory::ConditionTrialStartForecastRow](docs/ConditionTrialStartForecastRow.md)
|
|
275
328
|
- [PharmaObservatory::ConditionTrialsResponse](docs/ConditionTrialsResponse.md)
|
|
276
329
|
- [PharmaObservatory::ConditionTrialsRow](docs/ConditionTrialsRow.md)
|
|
277
330
|
- [PharmaObservatory::ConditionsRecord](docs/ConditionsRecord.md)
|
|
@@ -288,10 +341,26 @@ Class | Method | HTTP request | Description
|
|
|
288
341
|
- [PharmaObservatory::DrugPatentCliffRow](docs/DrugPatentCliffRow.md)
|
|
289
342
|
- [PharmaObservatory::InstitutionalHoldingsResponse](docs/InstitutionalHoldingsResponse.md)
|
|
290
343
|
- [PharmaObservatory::InstitutionalHoldingsRow](docs/InstitutionalHoldingsRow.md)
|
|
344
|
+
- [PharmaObservatory::InvestorFundsResponse](docs/InvestorFundsResponse.md)
|
|
345
|
+
- [PharmaObservatory::InvestorFundsRow](docs/InvestorFundsRow.md)
|
|
346
|
+
- [PharmaObservatory::InvestorPortfolioResponse](docs/InvestorPortfolioResponse.md)
|
|
347
|
+
- [PharmaObservatory::InvestorPortfolioRow](docs/InvestorPortfolioRow.md)
|
|
348
|
+
- [PharmaObservatory::InvestorPrivateFundsResponse](docs/InvestorPrivateFundsResponse.md)
|
|
349
|
+
- [PharmaObservatory::InvestorPrivateFundsRow](docs/InvestorPrivateFundsRow.md)
|
|
350
|
+
- [PharmaObservatory::InvestorsRecord](docs/InvestorsRecord.md)
|
|
351
|
+
- [PharmaObservatory::InvestorsResponse](docs/InvestorsResponse.md)
|
|
352
|
+
- [PharmaObservatory::InvestorsRow](docs/InvestorsRow.md)
|
|
291
353
|
- [PharmaObservatory::LegalEntitiesRecord](docs/LegalEntitiesRecord.md)
|
|
292
354
|
- [PharmaObservatory::LegalEntitiesRecordAttributes](docs/LegalEntitiesRecordAttributes.md)
|
|
293
355
|
- [PharmaObservatory::LegalEntitiesResponse](docs/LegalEntitiesResponse.md)
|
|
294
356
|
- [PharmaObservatory::LegalEntitiesRow](docs/LegalEntitiesRow.md)
|
|
357
|
+
- [PharmaObservatory::ManagersRecord](docs/ManagersRecord.md)
|
|
358
|
+
- [PharmaObservatory::ManagersResponse](docs/ManagersResponse.md)
|
|
359
|
+
- [PharmaObservatory::ManagersRow](docs/ManagersRow.md)
|
|
360
|
+
- [PharmaObservatory::OrgDisclosuresResponse](docs/OrgDisclosuresResponse.md)
|
|
361
|
+
- [PharmaObservatory::OrgDisclosuresRow](docs/OrgDisclosuresRow.md)
|
|
362
|
+
- [PharmaObservatory::OrgRelationshipsResponse](docs/OrgRelationshipsResponse.md)
|
|
363
|
+
- [PharmaObservatory::OrgRelationshipsRow](docs/OrgRelationshipsRow.md)
|
|
295
364
|
- [PharmaObservatory::OwnershipPositionsResponse](docs/OwnershipPositionsResponse.md)
|
|
296
365
|
- [PharmaObservatory::OwnershipPositionsRow](docs/OwnershipPositionsRow.md)
|
|
297
366
|
- [PharmaObservatory::PdufaDatesResponse](docs/PdufaDatesResponse.md)
|
|
@@ -327,6 +396,36 @@ Class | Method | HTTP request | Description
|
|
|
327
396
|
- [PharmaObservatory::SponsorTrialStartForecastRow](docs/SponsorTrialStartForecastRow.md)
|
|
328
397
|
- [PharmaObservatory::SponsorTrialsResponse](docs/SponsorTrialsResponse.md)
|
|
329
398
|
- [PharmaObservatory::SponsorTrialsRow](docs/SponsorTrialsRow.md)
|
|
399
|
+
- [PharmaObservatory::SupplierCapabilityEsgResponse](docs/SupplierCapabilityEsgResponse.md)
|
|
400
|
+
- [PharmaObservatory::SupplierCapabilityEsgRow](docs/SupplierCapabilityEsgRow.md)
|
|
401
|
+
- [PharmaObservatory::SupplierServicesResponse](docs/SupplierServicesResponse.md)
|
|
402
|
+
- [PharmaObservatory::SupplierServicesRow](docs/SupplierServicesRow.md)
|
|
403
|
+
- [PharmaObservatory::SupplierSitesResponse](docs/SupplierSitesResponse.md)
|
|
404
|
+
- [PharmaObservatory::SupplierSitesRow](docs/SupplierSitesRow.md)
|
|
405
|
+
- [PharmaObservatory::SuppliersRecord](docs/SuppliersRecord.md)
|
|
406
|
+
- [PharmaObservatory::SuppliersResponse](docs/SuppliersResponse.md)
|
|
407
|
+
- [PharmaObservatory::SuppliersRow](docs/SuppliersRow.md)
|
|
408
|
+
- [PharmaObservatory::TargetAssociationsResponse](docs/TargetAssociationsResponse.md)
|
|
409
|
+
- [PharmaObservatory::TargetAssociationsRow](docs/TargetAssociationsRow.md)
|
|
410
|
+
- [PharmaObservatory::TargetCrowdingResponse](docs/TargetCrowdingResponse.md)
|
|
411
|
+
- [PharmaObservatory::TargetCrowdingRow](docs/TargetCrowdingRow.md)
|
|
412
|
+
- [PharmaObservatory::TargetDrugsResponse](docs/TargetDrugsResponse.md)
|
|
413
|
+
- [PharmaObservatory::TargetDrugsRow](docs/TargetDrugsRow.md)
|
|
414
|
+
- [PharmaObservatory::TargetEvidenceResponse](docs/TargetEvidenceResponse.md)
|
|
415
|
+
- [PharmaObservatory::TargetEvidenceRow](docs/TargetEvidenceRow.md)
|
|
416
|
+
- [PharmaObservatory::TargetPatentMentionsResponse](docs/TargetPatentMentionsResponse.md)
|
|
417
|
+
- [PharmaObservatory::TargetPatentMentionsRow](docs/TargetPatentMentionsRow.md)
|
|
418
|
+
- [PharmaObservatory::TargetProgramsResponse](docs/TargetProgramsResponse.md)
|
|
419
|
+
- [PharmaObservatory::TargetProgramsRow](docs/TargetProgramsRow.md)
|
|
420
|
+
- [PharmaObservatory::TargetPublicationsResponse](docs/TargetPublicationsResponse.md)
|
|
421
|
+
- [PharmaObservatory::TargetPublicationsRow](docs/TargetPublicationsRow.md)
|
|
422
|
+
- [PharmaObservatory::TargetRegulatoryPrecedentResponse](docs/TargetRegulatoryPrecedentResponse.md)
|
|
423
|
+
- [PharmaObservatory::TargetRegulatoryPrecedentRow](docs/TargetRegulatoryPrecedentRow.md)
|
|
424
|
+
- [PharmaObservatory::TargetTrialsResponse](docs/TargetTrialsResponse.md)
|
|
425
|
+
- [PharmaObservatory::TargetTrialsRow](docs/TargetTrialsRow.md)
|
|
426
|
+
- [PharmaObservatory::TargetsRecord](docs/TargetsRecord.md)
|
|
427
|
+
- [PharmaObservatory::TargetsResponse](docs/TargetsResponse.md)
|
|
428
|
+
- [PharmaObservatory::TargetsRow](docs/TargetsRow.md)
|
|
330
429
|
- [PharmaObservatory::TrialAdverseEventsResponse](docs/TrialAdverseEventsResponse.md)
|
|
331
430
|
- [PharmaObservatory::TrialAdverseEventsRow](docs/TrialAdverseEventsRow.md)
|
|
332
431
|
- [PharmaObservatory::TrialChangesResponse](docs/TrialChangesResponse.md)
|
|
@@ -335,6 +434,8 @@ Class | Method | HTTP request | Description
|
|
|
335
434
|
- [PharmaObservatory::TrialDeliveryRow](docs/TrialDeliveryRow.md)
|
|
336
435
|
- [PharmaObservatory::TrialDemographicsResponse](docs/TrialDemographicsResponse.md)
|
|
337
436
|
- [PharmaObservatory::TrialDemographicsRow](docs/TrialDemographicsRow.md)
|
|
437
|
+
- [PharmaObservatory::TrialDrugClassesResponse](docs/TrialDrugClassesResponse.md)
|
|
438
|
+
- [PharmaObservatory::TrialDrugClassesRow](docs/TrialDrugClassesRow.md)
|
|
338
439
|
- [PharmaObservatory::TrialDrugsResponse](docs/TrialDrugsResponse.md)
|
|
339
440
|
- [PharmaObservatory::TrialDrugsRow](docs/TrialDrugsRow.md)
|
|
340
441
|
- [PharmaObservatory::TrialEnrollmentHistoryResponse](docs/TrialEnrollmentHistoryResponse.md)
|
|
@@ -343,8 +444,14 @@ Class | Method | HTTP request | Description
|
|
|
343
444
|
- [PharmaObservatory::TrialEnrollmentRateRow](docs/TrialEnrollmentRateRow.md)
|
|
344
445
|
- [PharmaObservatory::TrialExtractedEndpointsResponse](docs/TrialExtractedEndpointsResponse.md)
|
|
345
446
|
- [PharmaObservatory::TrialExtractedEndpointsRow](docs/TrialExtractedEndpointsRow.md)
|
|
447
|
+
- [PharmaObservatory::TrialKolsResponse](docs/TrialKolsResponse.md)
|
|
448
|
+
- [PharmaObservatory::TrialKolsRow](docs/TrialKolsRow.md)
|
|
346
449
|
- [PharmaObservatory::TrialOutcomeMeasuresResponse](docs/TrialOutcomeMeasuresResponse.md)
|
|
347
450
|
- [PharmaObservatory::TrialOutcomeMeasuresRow](docs/TrialOutcomeMeasuresRow.md)
|
|
451
|
+
- [PharmaObservatory::TrialResearchPaymentsResponse](docs/TrialResearchPaymentsResponse.md)
|
|
452
|
+
- [PharmaObservatory::TrialResearchPaymentsRow](docs/TrialResearchPaymentsRow.md)
|
|
453
|
+
- [PharmaObservatory::TrialSiteHistoryResponse](docs/TrialSiteHistoryResponse.md)
|
|
454
|
+
- [PharmaObservatory::TrialSiteHistoryRow](docs/TrialSiteHistoryRow.md)
|
|
348
455
|
- [PharmaObservatory::TrialSitesResponse](docs/TrialSitesResponse.md)
|
|
349
456
|
- [PharmaObservatory::TrialSitesRow](docs/TrialSitesRow.md)
|
|
350
457
|
- [PharmaObservatory::TrialsRecord](docs/TrialsRecord.md)
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayEvidenceResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<BiomarkerAssayEvidenceRow>**](BiomarkerAssayEvidenceRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::BiomarkerAssayEvidenceResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -1,4 +1,4 @@
|
|
|
1
|
-
# PharmaObservatory::
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayEvidenceResponseBuild
|
|
2
2
|
|
|
3
3
|
## Properties
|
|
4
4
|
|
|
@@ -12,7 +12,7 @@
|
|
|
12
12
|
```ruby
|
|
13
13
|
require 'pharmaobservatory'
|
|
14
14
|
|
|
15
|
-
instance = PharmaObservatory::
|
|
15
|
+
instance = PharmaObservatory::BiomarkerAssayEvidenceResponseBuild.new(
|
|
16
16
|
generation: null,
|
|
17
17
|
fingerprint: null
|
|
18
18
|
)
|
data/docs/{BiomarkerCdxAssertionsResponseFreshness.md → BiomarkerAssayEvidenceResponseFreshness.md}
RENAMED
|
@@ -1,4 +1,4 @@
|
|
|
1
|
-
# PharmaObservatory::
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayEvidenceResponseFreshness
|
|
2
2
|
|
|
3
3
|
## Properties
|
|
4
4
|
|
|
@@ -12,7 +12,7 @@
|
|
|
12
12
|
```ruby
|
|
13
13
|
require 'pharmaobservatory'
|
|
14
14
|
|
|
15
|
-
instance = PharmaObservatory::
|
|
15
|
+
instance = PharmaObservatory::BiomarkerAssayEvidenceResponseFreshness.new(
|
|
16
16
|
source: null,
|
|
17
17
|
last_loaded: null
|
|
18
18
|
)
|
|
@@ -1,4 +1,4 @@
|
|
|
1
|
-
# PharmaObservatory::
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayEvidenceResponseScope
|
|
2
2
|
|
|
3
3
|
## Properties
|
|
4
4
|
|
|
@@ -13,7 +13,7 @@
|
|
|
13
13
|
```ruby
|
|
14
14
|
require 'pharmaobservatory'
|
|
15
15
|
|
|
16
|
-
instance = PharmaObservatory::
|
|
16
|
+
instance = PharmaObservatory::BiomarkerAssayEvidenceResponseScope.new(
|
|
17
17
|
kind: null,
|
|
18
18
|
group_id: null,
|
|
19
19
|
group_name: null
|
|
@@ -0,0 +1,68 @@
|
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayEvidenceRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **biomarker_assay_evidence_id** | **String** | The extracted mention's id. | [optional] |
|
|
8
|
+
| **route_key** | **String** | The route key of the gene the mention resolved to, the entry key for the biomarkers object type. Null when the gene did not resolve. | [optional] |
|
|
9
|
+
| **biomarker_id** | **String** | The resolved gene's biomarker key. Null when the gene did not resolve. | [optional] |
|
|
10
|
+
| **document_id** | **String** | The id of the source document the facts were extracted from. | [optional] |
|
|
11
|
+
| **pmid** | **String** | The PubMed id of the paper. | [optional] |
|
|
12
|
+
| **biomarker_ordinal** | **Integer** | The position of the mention in the paper's extracted biomarker list, from 1. | [optional] |
|
|
13
|
+
| **biomarker_name_as_extracted** | **String** | The biomarker name as extracted. | [optional] |
|
|
14
|
+
| **gene_symbol_as_extracted** | **String** | The gene symbol as extracted, before resolution. Null when the mention names no gene. | [optional] |
|
|
15
|
+
| **biomarker_synonyms** | **Array<String>** | The synonyms the paper gives, a document-level list repeated on each of its rows. | [optional] |
|
|
16
|
+
| **gene_resolution_status** | **String** | How the mention resolved to a gene. resolved_direct: exact symbol match. resolved_alias: an unambiguous dictionary alias. unresolved: a symbol was extracted that matches nothing or an ambiguous alias; not guessed. not_applicable: no gene symbol was extracted. | [optional] |
|
|
17
|
+
| **gene_resolution_method** | **String** | exact_gene_symbol or dictionary_alias; null when the gene did not resolve. | [optional] |
|
|
18
|
+
| **assay_name** | **String** | The assay, trade name or platform the paper names. A document-level value. | [optional] |
|
|
19
|
+
| **specimen_type** | **String** | The specimen type (blood, plasma, tissue). A document-level value. | [optional] |
|
|
20
|
+
| **comparator_method** | **String** | The reference method the performance was measured against, when reported. | [optional] |
|
|
21
|
+
| **reported_performance** | **String** | The performance as the paper states it (sensitivity, specificity, area under the curve), as text and not computed. | [optional] |
|
|
22
|
+
| **validation_type_mentioned** | **String** | What the paper claims about the validation type: a fact about the text, not a tier. | [optional] |
|
|
23
|
+
| **assay_provider_company** | **Array<String>** | Organization names as extracted that run or provide the assay. Not resolved to a company. | [optional] |
|
|
24
|
+
| **funding_organizations** | **Array<String>** | Organization names as extracted that funded the study. Never merged with the assay provider. | [optional] |
|
|
25
|
+
| **evidence_type** | **String** | Always literature_assay_validation, which tells these rows from the other evidence types. | [optional] |
|
|
26
|
+
| **evidence_quote** | **Array<String>** | The sentences of the paper the facts were read from. Null when the extraction gave none. | [optional] |
|
|
27
|
+
| **confidence** | **String** | The extraction model's self-reported confidence. Not a reliability signal: it does not track whether the extraction is correct; never use it as a quality gate. | [optional] |
|
|
28
|
+
| **title** | **String** | The paper's title. | [optional] |
|
|
29
|
+
| **published_at** | **Time** | The paper's publication timestamp, in UTC. Null for about one paper in seven, whose source gives a bare year. | [optional] |
|
|
30
|
+
| **extraction_model** | **String** | The model that extracted the facts. | [optional] |
|
|
31
|
+
| **extracted_at** | **Time** | When the facts were extracted, in UTC. | [optional] |
|
|
32
|
+
| **source_url** | **String** | The address of the paper the facts were extracted from. | [optional] |
|
|
33
|
+
|
|
34
|
+
## Example
|
|
35
|
+
|
|
36
|
+
```ruby
|
|
37
|
+
require 'pharmaobservatory'
|
|
38
|
+
|
|
39
|
+
instance = PharmaObservatory::BiomarkerAssayEvidenceRow.new(
|
|
40
|
+
biomarker_assay_evidence_id: null,
|
|
41
|
+
route_key: null,
|
|
42
|
+
biomarker_id: null,
|
|
43
|
+
document_id: null,
|
|
44
|
+
pmid: null,
|
|
45
|
+
biomarker_ordinal: null,
|
|
46
|
+
biomarker_name_as_extracted: null,
|
|
47
|
+
gene_symbol_as_extracted: null,
|
|
48
|
+
biomarker_synonyms: null,
|
|
49
|
+
gene_resolution_status: null,
|
|
50
|
+
gene_resolution_method: null,
|
|
51
|
+
assay_name: null,
|
|
52
|
+
specimen_type: null,
|
|
53
|
+
comparator_method: null,
|
|
54
|
+
reported_performance: null,
|
|
55
|
+
validation_type_mentioned: null,
|
|
56
|
+
assay_provider_company: null,
|
|
57
|
+
funding_organizations: null,
|
|
58
|
+
evidence_type: null,
|
|
59
|
+
evidence_quote: null,
|
|
60
|
+
confidence: null,
|
|
61
|
+
title: null,
|
|
62
|
+
published_at: null,
|
|
63
|
+
extraction_model: null,
|
|
64
|
+
extracted_at: null,
|
|
65
|
+
source_url: null
|
|
66
|
+
)
|
|
67
|
+
```
|
|
68
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayWhitespaceResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<BiomarkerAssayWhitespaceRow>**](BiomarkerAssayWhitespaceRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::BiomarkerAssayWhitespaceResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,66 @@
|
|
|
1
|
+
# PharmaObservatory::BiomarkerAssayWhitespaceRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **biomarker_id** | **String** | The gene's biomarker key. | [optional] |
|
|
8
|
+
| **route_key** | **String** | The gene's route key, the entry key for the biomarkers object type; the gene symbol. | [optional] |
|
|
9
|
+
| **gene_symbol** | **String** | The gene symbol. | [optional] |
|
|
10
|
+
| **biomarker_display_name** | **String** | The gene's display name. | [optional] |
|
|
11
|
+
| **biomarker_identity_status** | **String** | Whether the gene's identity is confirmed. | [optional] |
|
|
12
|
+
| **target_id** | **String** | The target's Ensembl gene id; null when the gene does not resolve one, in which case the pipeline columns are null. | [optional] |
|
|
13
|
+
| **whitespace_bucket** | **String** | The classification, one of nine values crossing gene_evidence_tier with gene_supply_status. Labels: no_evidence_no_supply 'No evidence, explicit no-assay'; no_evidence_supply_ambiguous 'No evidence, ambiguous supply'; supply_no_evidence 'Supply declared, no evidence'; literature_evidence_no_supply 'Literature evidence, no confirmed supply'; literature_evidence_supply_ambiguous 'Literature evidence, ambiguous supply'; literature_evidence_served 'Literature evidence, supply declared'; validated_evidence_no_supply 'Validated-ladder evidence, no confirmed supply'; validated_evidence_supply_ambiguous 'Validated-ladder evidence, ambiguous supply'; served 'Validated-ladder evidence, supply declared'. | [optional] |
|
|
14
|
+
| **whitespace_bucket_rule_id** | **String** | The rule that assigned the bucket, one rule per bucket. | [optional] |
|
|
15
|
+
| **gene_evidence_tier** | **String** | Evidence axis, a precedence and not a score. validated: at least one row of the validation ladder (biomarker_validation) for the gene. literature_only: no validated row but at least one extracted PubMed assay fact. none: neither. | [optional] |
|
|
16
|
+
| **gene_supply_status** | **String** | Supply axis, a precedence. declared_positive: a supplier declares an assay (validated or not). declared_ambiguous: a response conflicts or gives detail with no option chosen. declared_no_assay: a supplier answered that it has no assay. not_on_survey: no answer at all. | [optional] |
|
|
17
|
+
| **validated_evidence_row_count** | **Integer** | Rows of the validation ladder for the gene (biomarker_validation). A count, not a score, and not combined with the literature count. | [optional] |
|
|
18
|
+
| **literature_evidence_row_count** | **Integer** | Extracted PubMed assay facts resolved to the gene (biomarker_assay_evidence). A count, not a score. | [optional] |
|
|
19
|
+
| **evidence_types_present** | **Array<String>** | The sorted set of evidence types behind the gene's evidence, including literature_assay_validation when literature evidence exists. A set, never a rank. | [optional] |
|
|
20
|
+
| **evidence_tier_rule_ids_present** | **Array<String>** | The sorted set of validation ladder rule ids behind the validated evidence. For display; do not derive a rank from it. | [optional] |
|
|
21
|
+
| **evidence_validation_ids** | **Array<String>** | biomarker_validation_id values of the validated evidence. Empty when gene_evidence_tier is not validated. | [optional] |
|
|
22
|
+
| **literature_evidence_ids** | **Array<String>** | biomarker_assay_evidence_id values of the extracted PubMed facts. Populated whichever evidence tier governs the bucket. | [optional] |
|
|
23
|
+
| **literature_evidence_document_ids** | **Array<String>** | The source document ids behind literature_evidence_ids. | [optional] |
|
|
24
|
+
| **supplier_declaration_ids** | **Array<String>** | Ids of the supplier survey declarations behind gene_supply_status (the winning precedence tier). Empty when not_on_survey. The declarations are not a published dataset. | [optional] |
|
|
25
|
+
| **supplier_positive_response_count** | **Integer** | Supplier declarations that an assay exists, validated or unvalidated, for the gene. | [optional] |
|
|
26
|
+
| **supplier_conflicting_response_count** | **Integer** | Declarations whose own cells disagree. | [optional] |
|
|
27
|
+
| **supplier_detail_only_response_count** | **Integer** | Declarations that give free text and no selected option. | [optional] |
|
|
28
|
+
| **supplier_no_assay_response_count** | **Integer** | Declarations that the supplier has no assay for the gene. | [optional] |
|
|
29
|
+
| **pipeline_program_count** | **Integer** | Drug programs against the gene's target across every phase band. Null means the gene has no target row, never zero activity. Heat only; not part of the bucket. | [optional] |
|
|
30
|
+
| **pipeline_active_program_count** | **Integer** | Active drug programs against the gene's target. Same nullability as pipeline_program_count. | [optional] |
|
|
31
|
+
| **pipeline_max_phase** | **Integer** | The highest phase band (0 to 4) any program against the target reached; the app maps it to a phase label. Null as pipeline_program_count. | [optional] |
|
|
32
|
+
|
|
33
|
+
## Example
|
|
34
|
+
|
|
35
|
+
```ruby
|
|
36
|
+
require 'pharmaobservatory'
|
|
37
|
+
|
|
38
|
+
instance = PharmaObservatory::BiomarkerAssayWhitespaceRow.new(
|
|
39
|
+
biomarker_id: null,
|
|
40
|
+
route_key: null,
|
|
41
|
+
gene_symbol: null,
|
|
42
|
+
biomarker_display_name: null,
|
|
43
|
+
biomarker_identity_status: null,
|
|
44
|
+
target_id: null,
|
|
45
|
+
whitespace_bucket: null,
|
|
46
|
+
whitespace_bucket_rule_id: null,
|
|
47
|
+
gene_evidence_tier: null,
|
|
48
|
+
gene_supply_status: null,
|
|
49
|
+
validated_evidence_row_count: null,
|
|
50
|
+
literature_evidence_row_count: null,
|
|
51
|
+
evidence_types_present: null,
|
|
52
|
+
evidence_tier_rule_ids_present: null,
|
|
53
|
+
evidence_validation_ids: null,
|
|
54
|
+
literature_evidence_ids: null,
|
|
55
|
+
literature_evidence_document_ids: null,
|
|
56
|
+
supplier_declaration_ids: null,
|
|
57
|
+
supplier_positive_response_count: null,
|
|
58
|
+
supplier_conflicting_response_count: null,
|
|
59
|
+
supplier_detail_only_response_count: null,
|
|
60
|
+
supplier_no_assay_response_count: null,
|
|
61
|
+
pipeline_program_count: null,
|
|
62
|
+
pipeline_active_program_count: null,
|
|
63
|
+
pipeline_max_phase: null
|
|
64
|
+
)
|
|
65
|
+
```
|
|
66
|
+
|
|
@@ -8,7 +8,7 @@
|
|
|
8
8
|
| **grain** | **String** | | [optional] |
|
|
9
9
|
| **object_type** | **String** | | [optional] |
|
|
10
10
|
| **id** | **String** | | [optional] |
|
|
11
|
-
| **scope** | [**
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
12
|
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
13
|
| **rows** | [**Array<BiomarkerBqpAssertionsRow>**](BiomarkerBqpAssertionsRow.md) | | |
|
|
14
14
|
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
@@ -21,8 +21,8 @@
|
|
|
21
21
|
| **source_credit** | **String** | | [optional] |
|
|
22
22
|
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
23
|
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
-
| **freshness** | [**
|
|
25
|
-
| **build** | [**
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
26
|
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
27
|
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
28
|
|